🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study to determine the effect of multiple-dose BBT-877 on the single-dose p...
Status
Completed
Location
Celerion
Start Date
2019-09-17
Trial ID
NCT04138836
Treatments Being Tested
The main purpose of this study is to assess the effect of selpercatinib on ...
Status
Completed
Location
Celerion
Start Date
2018-07-12
Trial ID
NCT05338476
Treatments Being Tested
Evaluation of oral midazolam to improve children's behavior and reduces the...
Status
Completed
Location
Faculty of Dentistry, Federal University of Goias
Start Date
2012-03
Trial ID
NCT01795222
Evaluate the safety and tolerability of sotorasib in adult subjects with KR...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2018-08-27
Trial ID
NCT03600883
Treatments Being Tested
This study is a drug-drug interaction (DDI), pharmacokinetics (PK), safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04493931
Treatments Being Tested
This study is designed to assess 1) the effect of multiple doses of itracon...
Status
Completed
Location
Celerion
Start Date
2019-10-18
Trial ID
NCT04142762
The purpose of this study is to determine the safety and tolerability of PA...
Status
Completed
Location
MDS Pharma Services
Start Date
2009-12
Trial ID
NCT01768273
Phase 1, open-label, non-randomized, three-treatment, one-sequence interact...
Status
Completed
Location
Research Site
Start Date
2025-05-14
Trial ID
NCT06979973
Treatments Being Tested
Drug-drug interaction (DDI) and Cardiodynamic Evaluation Study To assess th...
Status
Completed
Location
Celerion Clinical Research Unit
Start Date
2020-08-08
Trial ID
NCT04543370
Treatments Being Tested
The purpose of this study is to test the effects of study drug (GSK1605786)...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-09-19
Trial ID
NCT01489943
Treatments Being Tested